- A Visual Guide to Heart Disease
- Medical Illustrations of the Heart Image Collection
- Take the Heart Disease Quiz!
Does Kengreal (cangrelor) cause side effects?
Kengreal (cangrelor) is a type of anti-platelet drug called a P2Y12 inhibitor used during percutaneous coronary intervention (PCI) to reduce the risk of heart attacks, repeat coronary revascularization, and stent thrombosis (ST) in patients who have not been treated with another P2Y12 platelet inhibitor and are not receiving a glycoprotein IIb/IIIa inhibitor, another class of platelet inhibitor.
Kengreal prevents blood clots by reversibly binding to the P2Y12 receptor on platelets, preventing adenosine diphosphate (ADP) from activating platelets. It belongs to a class of drugs called P2Y12 inhibitors.
Kengreal is different from other P2Y12 inhibitors because it prevents clotting faster and its effect does not last as long after it is stopped. After administration, platelet inhibition begins within 2 minutes, lasts for the duration of the infusion, and platelet function returns to normal within 1 hour after stopping the infusion.
Common side effects of Kengreal include
- bleeding and
- shortness of breath.
Serious side effects of Kengreal include
Drug interactions of Kengreal include clopidogrel or prasugrel given during Kengreal infusion because they will have no antiplatelet effect until the next dose is given. Therefore, clopidogrel and prasugrel should not be given until the Kengreal infusion is stopped.
Use of Kengreal in pregnant females has not been adequately studied.
Kengreal (cangrelor) side effects list for healthcare professionals
The following adverse reactions are also discussed elsewhere in the labeling:
Clinical Trials Experience
Because clinical trials are conducted under widely varying conditions, adverse reactions rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
The safety of Kengreal has been evaluated in 13,301 subjects in controlled trials, in whom, 5,529 were in the Champion Phoenix trial.
There was a greater incidence of bleeding with Kengreal than with clopidogrel. No baseline demographic factor altered the relative risk of bleeding with Kengreal (see Table 1 and Figure 1).
Table 1: Major Bleeding Results in the Champion Phoenix Study (Non-CABG related Bleeding)a
|Any GUSTO bleeding, n (%)||857 (15.5)||602 (10.9)|
|Severe/life-threatening b||11 (0.2)||6 (0.1)|
|Moderate c||21 (0.4)||14 (0.3)|
|Mild d||825 (14.9)||582 (10.5)|
|Any TIMI bleeding, n (%)||45 (0.8)||17 (0.3)|
|Major e||12 (0.2)||6 (0.1)|
|Minor f||33 (0.6)||11 (0.2)|
|Abbreviations: GUSTO: Global
Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded
Arteries; TIMI: Thrombolysis in Myocardial Infarction
a Safety population is all randomized subjects who received at least one dose of study drug
b intracranial hemorrhage or bleeding resulting in substantial hemodynamic compromise requiring treatment
c requiring blood transfusion but not resulting in hemodynamic compromise
d all other bleeding not included in severe or moderate
e any intracranial hemorrhage, or any overt bleeding associated with a reduction in hemoglobin of ≥ 5 g/dL (or, when hemoglobin is not available, an absolute reduction in hematocrit ≥ 15%)
f any overt sign of bleeding (including observation by imaging techniques) that is associated with a reduction in hemoglobin of ≥ 3 g/dL and < 5 g/dL (or, when hemoglobin is not available, an absolute reduction in hematocrit of ≥ 9% and < 15%)
Figure 1: Bleeding Results in the Champion Phoenix
Studya (All Non-CABG related)
a Safety population is all randomized subjects who received at least one dose of study drug Note: The figure above presents effects in various subgroups most of which are baseline characteristics and most of which were pre-specified (patient presentation and weight were not pre-specified subgroups). The 95% confidence limits that are shown do not take into account how many comparisons were made, nor do they reflect the effect of a particular factor after adjustment for all other factors. Apparent homogeneity or heterogeneity among groups should not be over-interpreted.
- In Champion Phoenix the rate of discontinuation for bleeding events was 0.3% for Kengreal and 0.1% for clopidogrel.
- Discontinuation for non-bleeding adverse events was low and similar for Kengreal (0.6%) and for clopidogrel (0.4%).
- Coronary artery dissection, coronary artery perforation, and dyspnea were the most frequent events leading to discontinuation in patients treated with Kengreal.
Non-Bleeding Adverse Reactions
- Serious cases of hypersensitivity were more frequent with Kengreal (7/13301) than with control (2/12861).
- These included
Decreased renal function
- Worsening renal function was reported in 3.2% of Kengreal patients with severe renal impairment (creatinine clearance < 30 mL/min) compared to 1.4% of clopidogrel patients with severe renal impairment.
- Dyspnea was reported more frequently in patients treated with Kengreal (1.3%) than with control (0.4%).
What drugs interact with Kengreal (cangrelor)?
- If clopidogrel or prasugrel are administered during Kengreal infusion, they will have no antiplatelet effect until the next dose is administered.
- Clopidogrel and prasugrel, therefore, should not be administered until Kengreal infusion is discontinued.
Multimedia: Slideshows, Images & Quizzes
Heart Disease: Causes of a Heart Attack
Heart disease prevention includes controlling risk factors like diet, exercise, and stress. Heart disease symptoms in women may...
Am I Having a Heart Attack? Symptoms of Heart Disease
Heart attacks symptoms vary greatly for men and women, from anxiety and fatigue to nausea and sweating. Learn the warning signs...
Related Disease Conditions
Heart Attack Symptoms and Early Warning Signs
Recognizing heart attack symptoms and signs can help save your life or that of someone you love. Some heart attack symptoms, including left arm pain and chest pain, are well known but other, more nonspecific symptoms may be associated with a heart attack. Nausea, vomiting, malaise, indigestion, sweating, shortness of breath, and fatigue may signal a heart attack. Heart attack symptoms and signs in women may differ from those in men.
Can a Chest Muscle Strain Feel Like a Heart Attack?
Chest muscle strains can cause sudden, acute pain that feels like a heart attack. Learn the signs of a chest muscle strain, what causes it, how doctors diagnose it, and what you can do to treat it.
Heart Attack (Myocardial Infarction)
A heart attack happens when a blood clot completely obstructs a coronary artery supplying blood to the heart muscle. A heart attack can cause chest pain, heart failure, and electrical instability of the heart.
Second Source WebMD Medical Reference
Heart Attack vs. Heartburn
Heartburn is a symptom of another disease or medical problem and can be described as a feeling of burning in the chest accompanied by symptoms of nausea, vomiting, or a sour taste or food stuck in the back of the throat. Heart attack occurs when an artery in the heart is completely blocked by a blood clot, which causes that portion of heart muscle to die. Heart attack also has symptoms of chest pain, nausea, and vomiting, however, other warning signs and symptoms of a heart attack are unusual weakness or fatigue, and persistent and/or increased severity of symptoms over a few minutes. Heart attack is a life threatening emergency. If you think you or someone you are with is having a heart attack, call 911 immediately for urgent medical treatment. It may save your life.
Heart Attack vs. Stroke Symptoms, Differences, and Similarities
Heart attack usually is caused by a clot that stops blood flow supplying oxygen to an area of heart muscle, which results in heart muscle death. Stroke or "brain attack" is caused by a loss of blood supply to the brain (usually a blood clot) or by hemorrhagic stroke (bleeding within the brain), which results in brain tissue death. Both heart attack and stroke usually come on suddenly, produce similar symptoms, can be disabling, and can be fatal. The classic symptoms and warning signs of heart attack are different. Classic heart attack warning signs are chest pain or discomfort, shortness of breath, pain that radiates to the shoulders, back, arms, belly, jaw, or teeth, sweating, fainting, and nausea and vomiting. Moreover, woman having a heart attack may have additional symptoms like abdominal pain or discomfort, dizziness, clammy skin, and moderate to severe fatigue. The classic symptoms and warning signs that a person is having a stroke are confusion or loss of consciousness, sudden severe headache, speech problems, problems seeing out of one or both eyes, and numbness or weakness of only one side of the body. Moreover, a woman having a stroke may have additional warning symptom and signs like shortness of breath, disorientation, agitation, behavioral changes, weakness, nausea, vomiting, seizures, and hiccups. Recognition of stroke symptoms is vital for emergency treatment. The acronym "FAST" stands for recognition of Facial drooping, Arm weakness, Speech difficulty, and a Time for action. If you experience the symptoms heart attack or stroke (FAST) or see them develop in another person, then contact 911 immediately.
Heart Attack Treatment
A heart attack involves damage or death of part of the heart muscle due to a blood clot. The aim of heart attack treatment is to prevent or stop this damage to the heart muscle. Heart attack treatments included medications, procedures, and surgeries to protect the heart muscle against injury.
Heart Attacks in Women
Heart disease, particularly coronary artery disease is the leading cause of heart attacks. Women are more likely to die from a heart attack than men. High cholesterol, high blood pressure, obesity, and high triglycerides are contributors to heart disease. Some of the common symptoms of a heart attack in women include chest pain, shortness of breath, nausea, feeling faint or woozy, and more. Heart disease can be prevented by lifestyle changes and controlling high blood pressure, cholesterol, weight, and diseases such as diabetes.
Heart Attack Pathology: Photo Essay
A heart attack is a layperson's term for a sudden blockage of a coronary artery. This photo essay includes graphics, pictures, and illustrations of diseased heart tissue and the mechanisms that lead to coronary artery disease, and possible heart attack. A coronary artery occlusion may be fatal, but most patients survive it. Death can occur when the occlusion leads to an abnormal heartbeat (severe arrhythmia) or death of heart muscle (extensive myocardial infarction).
What Are the Four Signs of an Impending Heart Attack?
A heart attack occurs when the blood vessel that supplies blood to your heart (coronary artery) gets blocked – partially or completely. The lack of blood supply means the heart does not get enough oxygen or nutrients.
What Are the Signs of a Heart Attack in Women?
Many women think that the typical signs of a heart attack like crushing chest pain and shortness of breath can be easily recognized and cannot be missed. The 4 silent signs of a heart attack are fatigue, chest pain, pain in the upper back, shoulder, arms, neck or jaw, and sleep disturbances.
Heart Attack Prevention
Heart disease and heart attacks can be prevented by leading a healthy lifestyle with diet, exercise, and stress management. Symptoms of heart attack in men and women include chest discomfort and pain in the shoulder, neck, jaw, stomach, or back.
Vitamins & Exercise: Heart Attack Prevention Series
Vitamins and exercise can lower your risk for heart attack and heart disease. Folic acid, vitamins, and homocysteine levels are interconnected and affect your risk for heart disease or heart attack. For better heart health, avoid the following fried foods, hard margarine, commercial baked goods, most packaged and processed snack foods, high fat dairy, and processed meats such as bacon, sausage, and deli meats.
Heart Attack Prevention Overview
Heart attacks are the major causes of unexpected, sudden death among men and women. A heart attack also is a significant cause of heart failure. The process of developing atherosclerosis (hardening of the arteries) begins early in life. Heart attack prevention should begin in childhood because the atherosclerosis process can not be reversed. The risk of having a heart attack increases if you have diseases or conditions such as high blood pressure, diabetes, and other heart conditions.
What Is a Widowmaker Heart Attack?
A Widowmaker is a type of heart attack, which is deadlier than most others. A widowmaker heart attack occurs when the left ascending artery (LAD) that supplies blood to the front part of the heart (largest part) is clogged-up because of clots in the arterial wall. This causes the death of heart muscle in this area, medically termed myocardial infarction. Because the widowmaker damages a major portion of the heart, timely management is necessary to prevent fatalities.
Treatment & Diagnosis
- Heart Attack: A Tale of Two Heart Attacks
- Heart Attack Prevention From a Doctor's Perspective
- Heart Attack Risk and Medicated Stents
- FLAP Doubles Risk of Heart Attack
- The Cox-2 Inhibitors Controversy: Q&A with Dr. Shiel
- Heart Attack - New Blood Test For Earlier Accurate Diagnosis
- Cancer,Stroke & Heart Attack Risks- ReducedThrough Walking
- Heart Health- Little Aspirin A Day Stops Big Heart Attack!
- Heartburn or Heart Attack? Emergency In Flight
- Proven measures to prevent heart attacks and strokes?
- Any promising measures that may prevent heart attacks?
- Mr. Cheney's Chest Pain - And Heart Attack
- What Should Cholesterol Levels Be After Heart Attack?
- Do Women Have Different Heart Attack Symptoms?
- Will My Diet Slip Increase the Risk of Heart Attack?
- Can Asthma Cause a Heart Attack?
- Heart Attack Differences? Audio Podcast
- Heart Attack Symptoms Audio Podcast
Medications & Supplements
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Professional side effects and drug interactions sections courtesy of the U.S. Food and Drug Administration.